Disclaimer:  VFC has no affiliation with Titan Pharmaceuticals or with any third parties associated with the companies.  VFC has received no compensation for this blog post, although there may be an unrelated advertisement or two at various locations on this blog.  VFC does not offer advice or investment services and nothing you read here should be construed as such.  VFC is just a guy with an opinion and access to a computer and a keyboard; bringing discussion and ideas to the table.  #AhYeah.

Shares of Titan Pharmaceuticals (TTNP) are also worth watching this week.  

Titan is the proprietary owner and distributor of Probuphine, an implant a slow-releasing buprenorphine implant based on the company's ProNeura technology to treat opioid addiction.

Opioid addiction is a scourge of global society, helmed by not only the cartels and criminals, but by the biggest drug-pushers in the world - the pharmaceutical industry.  The amount of people dying from drug overdose rivals what we've seen from Covid19, but with less the fanfare.  Titan pharmaceuticals is in a prime position to take advantage of some of the treatment market share, especially since the Probuphine implant is slow-releasing and alleviates the threat of overdose.

Click 'Read more' below the ad to continue!  Great travel deals and discount codes with the link below!  Get ready for that post-covid travel!

Use this link for some awesome travel equipment!  Using the code READYPROAF15 will get you a 15% discount at checkout!  Ah yeah!

Read more

Disclaimer:  VFC has no affiliation with Cel-Sci Corp or with any third parties associated with the companies.  VFC has received no compensation for this blog post, although there may be an unrelated advertisement or two at various locations on this blog.  VFC does not offer advice or investment services and nothing you read here should be construed as such.  VFC is just a guy with an opinion and access to a computer and a keyboard; bringing discussion and ideas to the table.  #AhYeah.

If you haven't been paying attention to Cel-Sci Corp (CVM) yet, you might want to pay attention now.  We've discussed CVM many times on this blog over the course of the past decade as the company has taken its lead product candidate, Multikine, from successful Phase II trials through what is thought to be the largest head and neck cancer trial ever undertaken.  

Shares trades over two dollars higher (a nearly 20% price spike) on higher-than-normal volume on Friday, making it a stock to watch during the coming week.

If you are new to the CVM stock, take a read of the next couple of paragraphs for a quick catch-up on the Multikine story, as discussed in previous blog posts on VFC's Stock House.  If you're already caught up, skip the italics.

Why the interest?  

Cel-Sci is in the late stages of a robust Phase III trial testing Multikine, the company's lead developmental product, for the treatment of head and neck cancer.  Multikine is one of the newer breed of cancer immunotherapy treatments, which are designed to harness the body's own immune system to fight and possibly defeat cancer cells.  What is unique about Multikine, tho, is that the treatment is administered before the Standard of Care (SOC) treatment. 

Why is this significant? Click "Read more" below the ad (great airline deals, by the way) to continue!

Airfares are cheap these days, plan for that post-lockdown vacation now!  Put those stock winnings to good use!Travel, see the world and get some great airfare deals!

Fly Now, Pay Later. Easy monthly payments over 3, 6, or 12 months.

Read more

Regardless of whether you believe in "Medicare for All" or not, the Covid19crisis has let us know we need something.  The first world health care systems - public, private, and the socialized systems of Europe - were all woefully unprepared for this fight.  

The amount of money spent on producing and stockpiling weapons of war - missiles, tanks, land mines, rifles, grenades, you name it - and there's always more if needed; yet the stockpiles of weapons of life to arm our Doctors, Nurses and healthcare workers was simply just not there.  Priorities much, Governments of the World?
A lot of people with a lot of money have it pretty good - not just because they have a lot of money; but because the ignorance of living in a bubble keeps them out of touch from the real world where pain, fear, and suffering is felt every day.  Sending your kids to Spring Break in the middle of a growing pandemic?  Must be nice to be so oblivious to the world around you.
Click 'Read more' below for more...

Read more

This one isn't about stocks, or investing, or making money.  That can all wait for now.  What we need to do now is take this #COVID19 seriously.
If you’re still on the fence of taking this thing seriously or not, ya gotta get off the fence and take it seriously. Yes, some - in fact, most - fight off the virus fairly easily.  But many don’t.  Reading the press from around the world, there are everyday people of all ages succumbing to this virus, not just the elderly and those pre-stricken with other health conditions.  Everyone is at risk.  You don’t know who’s life you can be putting in danger by going about your routine business day in and day out. This is serious, treat it that way.
Continued with the link below....

Read more